BVBruna Krieger Vargas

Bruna Krieger Vargas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bruna Krieger Vargas has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioavailable Phenolic Compounds from Olive Pomace Present Anti-Neuroinflammatory Potential on Microglia Cells

    by Luana Schmidt, Bruna Krieger Vargas, Camila Sant’anna Monteiro, Lauren Pappis, Renius de Oliveira Mello, Alencar Kolinski Machado, Tatiana Emanuelli, Marco Antônio Zachia Ayub, José Cláudio Fonseca Moreira, Paula Rossini Augusti

    The neuroinflammatory process is considered one of the main characteristics of central nervous system diseases, where a pro-inflammatory response results in oxidative stress through the generation of reactive oxygen and nitrogen species (ROS and RNS). Olive (Olea europaea L.) pomace is a by-product of olive oil production that is rich in phenolic compounds (PCs), known for their antioxidant and anti-inflammatory properties. This work looked at the antioxidant and anti-neuroinflammatory effects of the bioavailable PC from olive pomace in cell-free models and microglia cells. The bioavailable PC of olive pomace was obtained through the process of in vitro gastrointestinal digestion of fractionated olive pomace (OPF, particles size < 2 mm) and micronized olive pomace (OPM, particles size < 20 µm). The profile of the PC that is present in the bioavailable fraction as well as its in vitro antioxidant capacity were determined. The anti-neuroinflammatory capacity of the bioavailable PC from olive pomace (0.03–3 mg L−1) was evaluated in BV-2 cells activated by lipopolysaccharide (LPS) for 24 h. The total bioavailable PC concentration and antioxidant activity against peroxyl radical were higher in the OPM than those observed in the OPF sample. The activation of BV-2 cells by LPS resulted in increased levels of ROS and nitric oxide (NO). The bioavailable PCs from both OPF and OPM, at their lowest concentrations, were able to reduce the ROS generation in activated BV-2 cells. In contrast, the highest PC concentration of OPF and OPM was able to reduce the NO levels in activated microglial cells. Our results demonstrate that bioavailable PCs from olive pomace can act as anti-neuroinflammatory agents in vitro, independent of particle size. Moreover, studies approaching ways to increase the bioavailability of PCs from olive pomace, as well as any possible toxic effects, are needed before a final statement on its nutritional use is made.


  • Gut Microbiota Modulation by Bioactive Compounds from Ilex paraguariensis: an In Vivo Study

    by Daiane Santos, Bruna Krieger Vargas, Elionio Galvão Frota, Bárbara Biduski, Samuel Teixeira Lopes, Júlia Pedó Gutkoski, Lára Franco dos Santos, Giseli Aparecida Ritterbusch, Rômulo Pillon Barcelos, Sabrina Somacal, et al.

    Yerba-mate (Ilex paraguariensis) is recognized for its biocompounds and bioactive properties. This study aimed to assess the potential of yerba-mate extract to modulate the intestinal microbiota in rats. After the ethical committee approval (CEUA – UPF, number 025/2018), the Wistar rats were given a daily dose of 3.29 mg of phenolic compounds per animal for 45 days. The antioxidant activity of the extract was assessed by ABTS and FRAP assays and the total phenolic compounds was measured at different pH levels. Identification and quantification of chlorogenic acid isomers were carried out using high-performance liquid chromatography (HPLC). Intestinal microbiota modulation was evaluated by administering the yerba-mate extract or water (control) to Wistar rats via intragastric gavage and its efficiency was measured through PCR. The antioxidant capacity of the yerba-mate extract was 64.53 ± 0.26 μmol Trolox/mL (ABTS) and 52.96 ± 0.86 μmol Trolox/mL (FRAP). The total phenolic compounds showed higher levels at pH 7.5 compared to pH 2.0. Chlorogenic acid isomers were found in greater abundance, with a concentration of 14.22 g/100 g. The administration of the extract resulted in positive modulation of the intestinal microbiota, specifically for the genera Lactobacillus sp. and Prevotella sp. The increase of these genera is related to the promotion of homeostasis of the gut microbiota. Therefore, these findings indicate that yerba-mate extract possesses significant antioxidant activity and can effectively modulate the intestinal microbiota in rats. These results support the potential use of yerba-mate as an alternative for controlling and preventing diseases associated with intestinal dysbiosis.


  • What is the role of phenolic compounds of yerba mate (Ilex paraguariensis) in gut microbiota?

    by Daiane Santos, Elionio Galvão Frota, Bruna Krieger Vargas, Cintia Cassia Tonieto Gris, Lára Franco dos Santos, Telma Elita Bertolin


  • Health effects and probiotic and prebiotic potential of Kombucha: A bibliometric and systematic review

    by Bruna Krieger Vargas, Mariana Fensterseifer Fabricio, Marco Antônio Záchia Ayub


  • In vitro digestibility and stability of encapsulated yerba mate extract and its impact on yogurt properties

    by Cintia Cassia Tonieto Gris, Elionio Galvão Frota, Cíntia Guarienti, Bruna Krieger Vargas, Julia Pedó Gutkoski, Bárbara Biduski, Telma Elita Bertolin


  • Clarification and concentration of yerba mate extract by membrane technology to increase shelf life

    by Lára Franco dos Santos, Bruna Krieger Vargas, Charise Dallazem Bertol, Bárbara Biduski, Telma Elita Bertolin, Luciana Ruschel dos Santos, Vandré Barbosa Brião